Circular NMC/CIR/2021/1441 of the National Medical Commission dated 20th July, 2021 on the manufacture of drugs [C11-ZT3]
As at 7 September 2026. In force. No commencement recorded.
NMC/CIR/2021/1441
National Medical Commission
New Delhi, dated the 20th July, 2021
CIRCULAR
To
All Inspectors,
Subject: The manufacture of drugs by manufacturers under the National Medical Commission Act, 2019, regarding.
In exercise of the powers conferred by section 9 of the National Medical Commission Act, 2019 (30 of 2019), the National Medical Commission hereby issues the following
1. References have been received seeking clarification on the manner in which section 9 applies to the manufacture of drugs by manufacturers.
2. The matter has been examined. Every manufacturer carrying on the manufacture of drugs shall make an application in Form 25 to the Central Government within ninety days, accompanied by a fee of two thousand rupees.
3. It is, accordingly, clarified that a separate application shall be made in respect of each place at which the manufacture of drugs is undertaken, and the Central Government shall dispose of it within ninety days of its receipt.
4. Difficulties, if any, in the implementation of this circular may be brought to the notice of the National Medical Commission.
(Chief General Manager)
Made under
Recital: "In exercise of the powers conferred by section 9 of the National Medical Commission Act, 2019 (30 of 2019), the National Medical Commission hereby issues the following". Names section 9 of the National Medical Commission Act, 2019 (30 of 2019) [S29-FQ7]. Vires verified.
Acts on (0)
none
Acted on by (0)
none
Not held (0)
none